Four-Drug attack on advanced colon cancer launches trial
NCT ID NCT07395063
Summary
This study is testing a new combination of four existing drugs for people with metastatic colorectal cancer that has continued to grow after their first treatment. The goal is to see if this four-drug mix can better control the cancer's growth, extend the time patients live without their disease getting worse, and is safe to use. It will involve about 68 adults whose cancer has spread and who have already tried one line of treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC COLORECTAL CANCER (CRC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.